Audience: Patients

Learn more about The Center for Data Driven Discovery in Biomedicine’s commitment to improve treatments and therapies for each and every patient.  Patients are partners in the research process, working together with researchers to better define the underpinnings of each unique tumor or disease.

Chordoma Foundation Biobank

Background The Chordoma Foundation (CF) biospecimens, clinical and genomic data via the expertise and tools created by the Center for Data Driven Discovery (D3b) at the Children’s Hospital…

Oligo Nation

Oligodendroglioma Oligodendroglioma (Oligo) is a primary malignant brain cancer that develops from Oligodendrocytes. Oligodendroglioma is one of the more common types of glioma (which also includes Glioblastoma Multiforme…

CHOP’s Center for Data Driven Discovery in Biomedicine Joins the Division of Neurosurgery and Neuro-Oncology Program to Honor Brain Tumor Awareness Month

According to the Central Brain Tumor Registry of the United States (CBTRUS), an estimated 86,970 new cases of primary malignant and non-malignant brain and central nervous system (CNS)…

#BrainTumorAwarenessMonth: Increased Support of Collaborative Brain Tumor Research is Critical to Improving Treatments and Discovering Cures for Children

*Note: This article comes courtesy of the Children’s Brain Tumor Network (CBTN), for which the Center for Data Drive Discovery in Biomedicine is the operations center.  The CBTN…

Design Principles

To accelerate translational research and the processing of data using the D³b Methodology, new platforms, research environments, and tools are required, which must be built on the following…